Leukemia & lymphoma/Leukemia and lymphoma · 2006 · 20 citations · 15 references
MedicineGeneticsMolecular GeneticsGenetic EpidemiologyMedical GeneticsPediatric GeneticsCancer RiskGenetic Risk AssessmentGenetic Risk FactorsGenotype-phenotype Association AnalysisMolecular Risk FactorsPediatric LeukemiasCase-control Study DesignFolate Metabolism GeneticsGene-environment AssociationsLeukemia RiskMendelian Risk FactorsMetabolic PolymorphismsMetabolism Enzyme PolymorphismsMethylenetetrahydrofolate Reductase Polymorphisms
Methylenetetrahydrofolate reductase (MTHFR) is an essential enzyme in the metabolism of folate. The presence of polymorphisms that reduce the activity of MTHFR has been linked to the multifactor process of development of acute leukemia. A case control study was conducted on Brazilian children in different regions of the country with the aim of investigating the role of MTHFR C677T and A1298C polymorphisms as risk factors in the development of acute myeloid leukemia (AML). We used the polymerase chain reaction restriction fragment length polymorphism method to genotyping 182 AML and 315 healthy individuals. The genotype 677 CT was associated with decreased risk [odds ratio (OR), 0.37; confidence interval (CI) 95%, 0.14 - 0.92], whereas 1298 AC genotype was linked with an increased risk [OR, 2.90; CI 95%, 1.26 - 6.71] of developing AML in non-white children. Further epidemiological study is needed to unravel the complex multiple gene-environment interactions in the role of the AML leukemogenesis.
15
Benjamin C. Blount, M. M. Mack, Carol M. Wehr et al. · Proceedings of the National Academy of Sciences · 1997 · 1.4K citations
Christine F. Skibola, Martyn T. Smith, Eleanor Kane et al. · Proceedings of the National Academy of Sciences · 1999 · 530 citations · Full text